Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin

被引：4

作者：

Latorre, C

García-Rey, C

García-Perea, A

Perea, E

Aguilar, L

Cercenado, E

García-de-Lomas, J

机构：

[1] GlaxoSmithKline, Dept Med, Madrid 28760, Spain

[2] Hosp St Joan Deu, Dept Microbiol, Barcelona, Spain

[3] Hosp La Paz, Dept Microbiol, Madrid, Spain

[4] Hosp Virgen Macarena, Dept Microbiol, Seville, Spain

[5] Hosp Gen Univ Gregorio Maranon, Dept Microbiol, Madrid, Spain

[6] Inst Valenciano Microbiol, Dept Microbiol, Sch Med, Valencia, Spain

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 02期

关键词：

D O I：

10.1093/jac/dkf116

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：301 / 302

页数：2

相关论文

共 8 条

[1] INVITRO ACTIVITY OF NEWER QUINOLONES AGAINST AEROBIC-BACTERIA
AUCKENTHALER, R
MICHEAHAMZEHPOUR, M
PECHERE, JC
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 : 29 - 39
[2] Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain:: Results of a 1-year (1996-1997) multicenter surveillance study
Baquero, F
García-Rodríguez, JA
de Lomas, JG
Aguilar, L
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 178 - 180
[3] Current concepts - Streptococcal infections of skin and soft tissues
Bisno, AL
Stevens, DL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) : 240 - 245
[4] Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
Chen, DK
McGeer, A
de Azavedo, JC
Low, DE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) : 233 - 239
[5] Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in spain
García-Rey, C
Aguilar, L
Baquero, F
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3481 - 3482
[6] Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997)
Granizo, JJ
Aguilar, L
Casal, J
Dal-Ré, R
Baquero, F
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 959 - 964
[7] National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS
[8] PEEZTRALLERO E, 2001, ANTIMICROBIAL AGENTS, V45, P3334